3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
beta-Thalassemia
1
Thalassemia
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Large Granular Lymphocytic
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Anemia, Sickle Cell
1
Interventions
Nivolumab
25
Specimen Handling
19
cabozantinib
15
Magnetic Resonance Spectroscopy
13
Ipilimumab
13
pembrolizumab
11
belzutifan
10
CTLA-4 Antigen
7
Biopsy
7
Axitinib
7
lenvatinib
5
atezolizumab
4
Sunitinib
4
tivozanib
3
Surveys and Questionnaires
3
Immunoglobulin G
3
Everolimus
3
Disulfides
3
zimberelimab
2
relatlimab
2
pazopanib
2
palbociclib
2
aldesleukin
2
X-Rays
2
Watchful Waiting
2
Radiosurgery
2
Nephrectomy
2
Bevacizumab
2
ulixertinib
1
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Renal Cell
×
thymoglobulin
×
30 days
×
Clear all
No trials found.